Evidence map›Paper›PMID 21620848›Full record

ArticleGastroenterology2011

Myc, Max, and Mnt: molecular mechanisms of enhancement of cholangiocarcinogenesis by cholestasis.

Ikuo Nakamura, Lewis R Roberts

Abstract readCommentEditorial
PubMed Full text at PMC Publisher
In one paragraph

Article in Gastroenterology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. The role of hypoxia-induced miR-210 in cancer progression.International journal of molecular sciences · 2015
    Review
  4. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Ikuo Nakamura
Lewis R Roberts

Funding

PILOT AND FEASIBILTY PROGRAMP30DK084567 · NIDDK · MAYO CLINIC ROCHESTER · PI GREGORY J. GORES · 2009 to 2026
$22.2M
Molecular Pathogenesis of Hepatocellular CarcinomaR01CA100882 · NCI · MAYO CLINIC ROCHESTER · PI ROBERTS, LEWIS R · 2004 to 2008
$1.8M
Dysregulation of the Tumor Microenvironment in Hepatocellular CarcinomaR21CA128633 · NCI · MAYO CLINIC ROCHESTER · PI ROBERTS, LEWIS R · 2009 to 2010
$366k
Molecular Pathogenesis of Hepatocellular CarcinomaR56CA100882 · NCI · MAYO CLINIC ROCHESTER · PI ROBERTS, LEWIS R · 2009 to 2009
$352k
NCI NIH HHS CA100882NCI NIH HHS CA128633NCI NIH HHS R01 CA100882NCI NIH HHS R21 CA128633NCI NIH HHS R56 CA100882NIDDK NIH HHS P30 DK084567NIDDK NIH HHS P30DK084567
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsBasic Helix-Loop-Helix Leucine Zipper Transcription FactorsBile Duct NeoplasmsBile Ducts, IntrahepaticCell Cycle ProteinsCholangiocarcinomaCholestasisDisease Models, AnimalDisease ProgressionGene Expression Regulation, NeoplasticHumansHyperplasiaLiverMiceMicroRNAsProto-Oncogene Proteins c-mycBasic Helix-Loop-Helix Leucine Zipper Transcription FactorsCell Cycle ProteinsMax protein, mouseMicroRNAsMnt protein, mouseMyc protein, mouseProto-Oncogene Proteins c-mycRepressor Proteins

Identifiers

PMID21620848
PMCPMC4040264

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.